Recent Updates — SYRA

Syra Health Corp. reported third-quarter 2026 financial results showing a record quarterly revenue of $2.6 million, up 52% year-over-year from $1.7 million. The company posted net income of $344,610, or $0.02 per share, compared to a net loss of $(225,902) in the prior-year period. Gross margin expanded significantly to 46.3%, and EBITDA turned positive at $301,725. For the first nine months of 2026, Syra Health generated net income of $835,831 and ended the quarter with $2.4 million in cash and no long-term debt. The company operates as an integrated healthcare solutions provider focusing on population health analytics, workforce staffing, and mental health technology.

Syra Health Corp. reported financial results for the second quarter ended June 30, 2026, achieving net income of $250,242 compared to a net loss in the prior-year period. Revenue grew 23% year-over-year to $2.4 million, driven by an 87% increase in healthcare workforce revenue and an 8% rise in population health solutions. Gross margin expanded to 44.5%, up from 38.7% in Q2 2025, while EBITDA turned positive at $253,200. The company secured contract extensions with Wake County Public Health and the Indiana Veterans’ Home, and received an amendment to its Indiana FSSA contract through October 2028. Cash on hand was $2.1 million with no long-term debt as of June 30, 2026. Syra Health operates in the healthcare solutions industry, providing prevention-focused services, workforce staffing, and analytics to government and commercial organizations.